Aerosol Research Articles & Analysis: Older
3 news found
Randomized, placebo-controlled, double-blind Phase II trial to treat 42 patients ongoing in four European countries with ESO-101 ESO-101, EsoCap’s lead product candidate, consists of a capsule with a rolled, thin mucoadhesive film, loaded with the anti-inflammatory corticosteroid, mometasone furoate In a previous trial, EsoCap’s proprietary and unique targeted application ...
Employees are adequately distanced in all office, shipping, and manufacturing spaces with the liberal use of clear plexiglas panels to lessen aerosolized transmission. Employees are also required to use separate stairways for up and down passage between floors. ...
Today, ONY Biotech announced the results of a clinical trial on its aerosolized surfactant for newborns with respiratory distress syndrome (RDS), a disorder caused by lack of surfactant that can result in collapsed lungs. ...